Table 2 Efficacy outcomes at weeks 9–12 of treatment
Treatment group | P | All | ||
|---|---|---|---|---|
Old policy (n = 146) | New policy (n = 63) | (n = 209) | ||
≥ 50% response rate in MHD, no. (%) | 55 (37.7%) | 40 (63.5%) | < 0.001 | 95 (45.5%) |
≥ 30% response rate in MHD, no. (%) | 83 (56.8%) | 49 (77.8%) | 0.004 | 132 (63.2%) |
Change in MHD at 3 months, mean (SD) | -5.02 (5.46) | -6.67 (5.32) | 0.045 | -5.52 (5.45) |
Old policy (n = 138) | New policy (n = 55) | All (n = 193) | ||
≥ 50% response rate in MMD, no. (%) | 56 (40.6%) | 33 (60.0%) | 0.015 | 89 (46.1%) |
≥ 30% response rate in MMD, no. (%) | 84 (60.9%) | 46 (83.6%) | 0.002 | 130 (67.4%) |
Change in MMD at 3 months, mean (SD) | -4.78 (5.02) | -6.12 (5.04) | 0.095 | -5.17 (5.05) |